Neos Therapeutics Reports First Quarter 2017 Financial Results
09 mai 2017 07h00 HE
|
Neos Therapeutics, Inc
DALLAS and FORT WORTH, Texas, May 09, 2017 (GLOBE NEWSWIRE) -- Neos Therapeutics, Inc. (NASDAQ:NEOS), a pharmaceutical company focused on developing, manufacturing and commercializing innovative...
Neos Therapeutics to Host First Quarter 2017 Financial Results Conference Call on May 9, 2017
02 mai 2017 07h30 HE
|
Neos Therapeutics, Inc
DALLAS and FORT WORTH, Texas, May 02, 2017 (GLOBE NEWSWIRE) -- Neos Therapeutics, Inc. (NASDAQ:NEOS), a pharmaceutical company focused on developing, manufacturing and commercializing innovative...
Neos Therapeutics Reports Fourth Quarter and Full Year 2016 Financial Results
14 mars 2017 07h00 HE
|
Neos Therapeutics, Inc
DALLAS and FORT WORTH, Texas, March 14, 2017 (GLOBE NEWSWIRE) -- Neos Therapeutics, Inc. (NASDAQ:NEOS), a pharmaceutical company focused on developing, manufacturing and commercializing innovative...
Neos Therapeutics to Host Fourth Quarter and Year-End 2016 Financial Results Conference Call on March 14, 2017
08 mars 2017 07h30 HE
|
Neos Therapeutics, Inc
DALLAS and FORT WORTH, Texas, March 08, 2017 (GLOBE NEWSWIRE) -- Neos Therapeutics, Inc. (NASDAQ:NEOS), a pharmaceutical company focused on developing, manufacturing and commercializing innovative...
Neos Therapeutics to Present at the Cowen and Company 37th Annual Health Care Conference
28 févr. 2017 07h30 HE
|
Neos Therapeutics, Inc
DALLAS and FORT WORTH, Texas, Feb. 28, 2017 (GLOBE NEWSWIRE) -- Neos Therapeutics, Inc. (NASDAQ:NEOS), a pharmaceutical company focused on developing, manufacturing and commercializing innovative...
Neos Therapeutics to Present at the RBC Capital Markets 2017 Global Healthcare Conference
16 févr. 2017 07h30 HE
|
Neos Therapeutics, Inc
DALLAS and FORT WORTH, Texas, Feb. 16, 2017 (GLOBE NEWSWIRE) -- Neos Therapeutics, Inc. (NASDAQ:NEOS), a pharmaceutical company focused on developing, manufacturing and commercializing innovative...
Neos Therapeutics Completes Resubmission of NDA for Cotempla XR-ODT for the Treatment of ADHD
20 déc. 2016 07h30 HE
|
Neos Therapeutics, Inc
DALLAS/FORT WORTH, Texas, Dec. 20, 2016 (GLOBE NEWSWIRE) -- Neos Therapeutics, Inc. (NASDAQ:NEOS), a pharmaceutical company focused on developing, manufacturing and commercializing innovative...
Neos Therapeutics to Present at BMO Prescription for Success Healthcare Conference
07 déc. 2016 08h00 HE
|
Neos Therapeutics, Inc
DALLAS/FORT WORTH, Texas, Dec. 07, 2016 (GLOBE NEWSWIRE) -- Neos Therapeutics, Inc. (NASDAQ:NEOS), a pharmaceutical company focused on developing and commercializing innovative extended-release...
Neos Therapeutics Submits NDA for Amphetamine Extended-Release Liquid Suspension Drug Candidate, NT-0201, for the Treatment of ADHD
17 nov. 2016 08h00 HE
|
Neos Therapeutics, Inc
DALLAS/FORT WORTH, Texas, Nov. 17, 2016 (GLOBE NEWSWIRE) -- Neos Therapeutics, Inc. (NASDAQ:NEOS), a pharmaceutical company focused on developing and commercializing innovative extended-release...
Neos Therapeutics Reports Third Quarter 2016 Financial Results
10 nov. 2016 07h00 HE
|
Neos Therapeutics, Inc
DALLAS/FORT WORTH, Texas, Nov. 10, 2016 (GLOBE NEWSWIRE) -- Neos Therapeutics, Inc. (NASDAQ:NEOS), a pharmaceutical company focused on developing, manufacturing and commercializing innovative...